Literature DB >> 18458910

Pace of macrophage recruitment during different stages of soft tissue infection: semi-quantitative evaluation by in vivo magnetic resonance imaging.

Jin Seong Lee1, Jin Young Sohn, Hyun-Don Jung, Sang-Tae Kim, Kyoung Geun Lee, Hee Jung Kang.   

Abstract

We describe the pace of recruitment of iron-oxide-labeled macrophages to the site of different stages of infection by in vivo magnetic resonance (MR) imaging. Peritoneal macrophages were labeled with superparamagnetic iron oxide ex vivo and administered through the tail vein 6 (acute) or 48 (subacute) h after bacterial inoculation. The legs of the mice were imaged sequentially on a 4.7-T MR unit before and 3, 6, 12, 18, 24, 48 and 72 h after macrophage administration. The band-shaped lower signal intensity zone around the abscess on T2*-weighted GRE images became more obvious due to recruited macrophages up until 24 h after injection in the subacute and 48 h after injection in the acute group, indicating that the relative SI of the abscess wall decreased more rapidly and the pace of recruitment of macrophages was faster in the subacute than in the acute group. Chemokine antibody arrays of mouse sera detected increased concentration of granulocyte-colony-stimulating factor and tissue inhibitor of metalloproteinase-1 beginning at 12 h and increased interleukin-13 at 18 h. Monocyte chemoattractant protein-1 and macrophage-colony-stimulating factor began to increase at 96 h after infection. This difference in pace of recruitment may result from the release of chemokines.

Entities:  

Mesh:

Year:  2008        PMID: 18458910     DOI: 10.1007/s00330-008-0975-0

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  18 in total

1.  MR imaging with ultrasmall superparamagnetic iron oxide particles in experimental soft-tissue infections in rats.

Authors:  Achim H Kaim; Thorsten Wischer; Terence O'Reilly; Gernot Jundt; Johannes Fröhlich; Gustav K von Schulthess; Peter R Allegrini
Journal:  Radiology       Date:  2002-12       Impact factor: 11.105

2.  In vivo magnetic resonance imaging of immune cells in the central nervous system with superparamagnetic antibodies.

Authors:  Istvan Pirko; Aaron Johnson; Bogoljub Ciric; Jeff Gamez; Slobodan I Macura; Larry R Pease; Moses Rodriguez
Journal:  FASEB J       Date:  2003-11-20       Impact factor: 5.191

3.  MR imaging of in vivo recruitment of iron oxide-labeled macrophages in experimentally induced soft-tissue infection in mice.

Authors:  Jin Seong Lee; Hee Jung Kang; Gyungyub Gong; Heun-Don Jung; Keun Ho Lim; Sang Tae Kim; Tae-Hwan Lim
Journal:  Radiology       Date:  2006-10       Impact factor: 11.105

4.  Migration of iron oxide-labeled human hematopoietic progenitor cells in a mouse model: in vivo monitoring with 1.5-T MR imaging equipment.

Authors:  Heike E Daldrup-Link; Martina Rudelius; Guido Piontek; Stephan Metz; Rosalinde Bräuer; Gerlinde Debus; Claire Corot; Jürgen Schlegel; Thomas M Link; Christian Peschel; Ernst J Rummeny; Robert A J Oostendorp
Journal:  Radiology       Date:  2005-01       Impact factor: 11.105

5.  Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells.

Authors:  M Lewin; N Carlesso; C H Tung; X W Tang; D Cory; D T Scadden; R Weissleder
Journal:  Nat Biotechnol       Date:  2000-04       Impact factor: 54.908

6.  In vivo macrophage activity imaging in the central nervous system detected by magnetic resonance.

Authors:  V Dousset; C Delalande; L Ballarino; B Quesson; D Seilhan; M Coussemacq; E Thiaudiére; B Brochet; P Canioni; J M Caillé
Journal:  Magn Reson Med       Date:  1999-02       Impact factor: 4.668

7.  Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro.

Authors:  Stephan Metz; Gabriel Bonaterra; Martina Rudelius; Marcus Settles; Ernst J Rummeny; Heike E Daldrup-Link
Journal:  Eur Radiol       Date:  2004-07-13       Impact factor: 5.315

8.  Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice.

Authors:  L Boring; J Gosling; S W Chensue; S L Kunkel; R V Farese; H E Broxmeyer; I F Charo
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

9.  In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors.

Authors:  Moritz F Kircher; Jennifer R Allport; Edward E Graves; Victoria Love; Lee Josephson; Andrew H Lichtman; Ralph Weissleder
Journal:  Cancer Res       Date:  2003-10-15       Impact factor: 12.701

10.  Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor.

Authors:  T Kurihara; G Warr; J Loy; R Bravo
Journal:  J Exp Med       Date:  1997-11-17       Impact factor: 14.307

View more
  4 in total

1.  Pathogenic role of macrophages in intradermal infection of methicillin-resistant Staphylococcus aureus in thermally injured mice.

Authors:  Akira Asai; Yasuhiro Tsuda; Makiko Kobayashi; Toshiaki Hanafusa; David N Herndon; Fujio Suzuki
Journal:  Infect Immun       Date:  2010-08-02       Impact factor: 3.441

2.  Macrophages homing to metastatic lymph nodes can be monitored with ultrasensitive ferromagnetic iron-oxide nanocubes and a 1.5T clinical MR scanner.

Authors:  Hye Rim Cho; Seung Hong Choi; Nohyun Lee; Taeghwan Hyeon; Hyeonjin Kim; Woo Kyung Moon
Journal:  PLoS One       Date:  2012-01-10       Impact factor: 3.240

3.  Neutrophil extracellular traps enhance macrophage killing of bacterial pathogens.

Authors:  Andrew J Monteith; Jeanette M Miller; C Noel Maxwell; Walter J Chazin; Eric P Skaar
Journal:  Sci Adv       Date:  2021-09-10       Impact factor: 14.136

4.  Bacteria tracking by in vivo magnetic resonance imaging.

Authors:  Verena Hoerr; Lorena Tuchscherr; Jana Hüve; Nadine Nippe; Karin Loser; Nataliya Glyvuk; Yaroslav Tsytsyura; Michael Holtkamp; Cord Sunderkötter; Uwe Karst; Jürgen Klingauf; Georg Peters; Bettina Löffler; Cornelius Faber
Journal:  BMC Biol       Date:  2013-05-28       Impact factor: 7.431

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.